Financhill
Back

Trevi Therapeutics Quote, Financials, Valuation and Earnings

Trevi Therapeutics Price Quote

$4.17

Trevi Therapeutics Key Stats

Buy
63
Trevi Therapeutics (TRVI) is a Buy

Day range:
$3.75 - $4.28
52-week range:
$1.22 - $4.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.69%

Volume:
4.2M
Avg. volume:
2.8M
1-year change:
228.35%
Market cap:
$276.7M
Revenue:
$0
EPS:
$-0.44

How Much Does Trevi Therapeutics Make?

Data Unavailable

Is Trevi Therapeutics Growing As A Company?

Data Unavailable

Trevi Therapeutics Stock Price Performance

What Is Trevi Therapeutics 52-Week High & Low?

Trevi Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Trevi Therapeutics?

Is Trevi Therapeutics Cash Flow Positive?

  • What Is TRVI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$35.1M
  • What Is Trevi Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10M
  • What Is Trevi Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $15.2M

Trevi Therapeutics Return On Invested Capital

Data Unavailable

Trevi Therapeutics Earnings Date & Stock Price

Trevi Therapeutics Competitors

Trevi Therapeutics Dividend Yield

Trevi Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -15.19%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 9.81
Upside from Last Price: 135.31%

Major Shareholders

  • How many TRVI shares are owned by institutional investors?
    62.7M TRVI shares are owned by institutional investors
  • How many TRVI shares are owned by insiders?
    1.1M TRVI shares are owned by insiders